Wirth, Wolfgang http://orcid.org/0000-0002-2297-8283
Eckstein, Felix
Kemnitz, Jana
Baumgartner, Christian Frederik
Konukoglu, Ender
Fuerst, David
Chaudhari, Akshay Sanjay
Funding for this research was provided by:
Paracelsus Medizinische Privatuniversität (PMU-FFF, E-18/27/146-WIK)
National Institutes of Health (N01-AR-2-2258, N01-AR-2-2259, N01-AR-2-2260, N01-AR-2-2261, N01-AR-2-2262)
Paracelsus Medical University
Article History
Received: 9 June 2020
Revised: 22 August 2020
Accepted: 10 September 2020
First Online: 6 October 2020
Compliance with ethical standards
:
: Wolfgang Wirth: Part-time employee and share-holder of Chondrometrics GmbH and received consulting fees from Galapagos N.V. Felix Eckstein: CEO/CMO and co-owner of Chondrometrics GmbH, and has provided consulting services to Merck KGaA, Samumed, Kolon-Tissuegene, Servier, Galapagos, Roche, Novartis, and ICM. Jana Kemnitz: Nothing to disclose. Christian F. Baumgartner: Nothing to disclose. Ender Konukoglu: Nothing to disclose. David Fuerst: Part-time employee of Chondrometrics GmbH. Akshay Chaudhari: Has provided consulting services to SkopeMR, Inc., Subtle Medical, Chondrometrics GmbH, Image Analysis Group, Edge Analytics, and Culvert Engineering; and is a shareholder of Subtle Medical, LVIS Corporation, and Brain Key.
: All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors. The Osteoarthritis Initiative (OAI) was approved by the Committee on Human Research, Institutional Review Board for the University of California, San Francisco. All OAI participants provided written informed consent, and this study was carried out in accordance with the OAI data user agreement.